Emerging therapies, including antibody-drug conjugates and biomarker-driven approaches, have the potential to significantly ...

Landmark trials have shown that GLP-1 receptor agonists, originally developed for diabetes and weight loss, also provide ...

In the rapidly evolving landscape of nuclear medicine, the integration of diagnostics and therapeutics - known as ...

The stroke market is experiencing unprecedented growth, fueled by intense corporate investment and disruptive technologies ...

Longing for the past? You’re not alone, and chances are, the place you’re missing is by the water. A new study found that ...

A panelist discusses how ASCO 2025's most important breakthrough was the oral decitabine plus venetoclax combination, representing a potential paradigm shift if approved by the FDA, while highlighting ...

Sarepta Therapeutics is refusing to pull its gene therapy Elevidys (delandistrogene moxeparvovec), despite a request from the FDA.

Business was booming for Swiss pharma giant Novartis in the second quarter of 2025 with 11% net sales growth riding strong ...

Müller produces her own tracks using professional-grade production software, layering frequencies to create deep neurological effects.

Optum and Illumina Inc. researchers documented that less than half of patients with newly diagnosed advanced cancers received ...

PSYPACT allows licensed psychologists to practice across state lines via telepsychology and temporary in-person services, ...